Doctor profile · Federal record
Dr. Lijo John, MD
Medical Oncology Physician (CMS: Internal Medicine) · Student in an Organized Health Care Education/Training Program · Internal Medicine Physician · Longview, TX
- NPI 1295050037
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1300 N 4Th St
Longview, TX 756014717
(903) 757-2122
fax (903) 757-9475 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- April 2010 — 16 yrs on file
- Profile last updated
- May 18, 2016
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #P7933
- Medicaid (2)
- TX #336215402 · TX #336215401
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295050037. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
126,443
Distinct HCPCS
10
Medicare allowed
$1,651,126
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 36,720 | 54 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 21,585 | 38 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,200 | 31 | $54 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,945 | 84 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 9,760 | 11 | $30 | |
J9267 |
Injection, paclitaxel, 1 mg | 7,986 | 27 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 6,700 | 17 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 6,100 | 11 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,544 | 79 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,268 | 398 | $8 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 1,582. This provider delivers 80× the peer median.Open Payments
Industry payments received
All-time total
$399
Transactions
22
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $82.25 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $78.93 | |
| GlaxoSmithKline, LLC. | 3 | $50.94 | |
| ABBVIE INC. | 2 | $48.70 | |
| Daiichi Sankyo Inc. | 1 | $27.01 | |
| Incyte Corporation | 1 | $25.00 | |
| Celgene Corporation | 1 | $18.72 | |
| Lilly USA, LLC | 1 | $18.16 | |
| Novartis Pharmaceuticals Corporation | 1 | $17.43 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $16.25 | |
| PFIZER INC. | 1 | $15.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
984
Patients
296
Total drug cost
$106,886
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 153 | 47 | $4,396 |
| Eliquis (Apixaban) | Brand | 109 | 23 | $86,433 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 99 | 35 | $3,025 |
| Levothyroxine Sodium | Generic | 94 | 29 | $1,312 |
| Dexamethasone | Generic | 72 | 35 | $1,781 |
| Prednisone | Generic | 66 | 15 | $863 |
| Hydroxyurea | Generic | 53 | 11 | $1,250 |
| Gabapentin | Generic | 50 | 15 | $941 |
| Pantoprazole Sodium | Generic | 44 | 11 | $255 |
| Fentanyl | Generic | 42 | 11 | $3,562 |
Hospital affiliations
Frequently asked questions
What is Dr. Lijo John's medical specialty?
Dr. Lijo John practices Medical Oncology Physician in Longview, TX.
Where does Dr. Lijo John practice?
Dr. Lijo John practices at 1300 N 4Th St, Longview, TX 756014717. Office phone: 9037572122.
What is Dr. Lijo John's NPI?
Dr. Lijo John's National Provider Identifier (NPI) is 1295050037, issued by NPPES.
Does Dr. Lijo John accept Medicare assignment?
Yes. Dr. Lijo John accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lijo John commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.